This case generated little coverage, a story in Bloomberg, and a post on PharmaLot, but perhaps should have received more attention. Back...
Home » Posts filed under Boehringer Ingelheim
Showing posts with label Boehringer Ingelheim. Show all posts
Showing posts with label Boehringer Ingelheim. Show all posts
Monday, May 11, 2015
"Can't This be Avoided?" - How Corporate Marketers Manipulated a Clinical Research Report to Avoid "Undermining" Marketing Messages
Documents newly made public in the course of litigation about the drug Pradaxa show granular details about how clinical research may be mani...
"Can't This be Avoided?" - How Corporate Marketers Manipulated a Clinical Research Report to Avoid "Undermining" Marketing Messages
Rating: 4.5
Diposkan Oleh:
Unknown
Sunday, May 10, 2015
Clinical Trial Prestidigitation - Making Old Data Look Worse So New Data Looks Better
Prestidigitation, also known as sleight of hand or legerdemain, is a form of stage magic which uses dextrous manipulation and misdirection ...
Clinical Trial Prestidigitation - Making Old Data Look Worse So New Data Looks Better
Rating: 4.5
Diposkan Oleh:
Unknown
Thursday, May 7, 2015
Fool Me Twice? - Boehringer Ingelheim, Medtronic Settle Lawsuits Alleging Deceptive Marketing
It seems like it has been really quiet on the legal settlement front in the US, but maybe corporate executives wanted to wait until things c...
Fool Me Twice? - Boehringer Ingelheim, Medtronic Settle Lawsuits Alleging Deceptive Marketing
Rating: 4.5
Diposkan Oleh:
Unknown
Wednesday, October 31, 2012
Just Another Day at the Office: Boehringer Ingelheim Settles Allegations of Deceptive Off-Label Marketing, Kickbacks
Legal settlements by pharmaceutical companies for less than $100 million now seem to barely rate as news in the US. The best report, albeit...
Just Another Day at the Office: Boehringer Ingelheim Settles Allegations of Deceptive Off-Label Marketing, Kickbacks
Rating: 4.5
Diposkan Oleh:
Unknown
Subscribe to:
Posts (Atom)
